Archive: 07/02/2018

Smallpox vaccine study yields favorable results

Officials from Bavarian Nordic yesterday announced the results of a successful Phase 3 clinical trial led by USAMRIID that demonstrated the safety and efficacy of the company's investigational, non-replicating smallpox vaccine, ...

page 2 from 10